Weidong Wang

Dr. Weidong Wang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2024 in International Journal of Surgery
Verified
Journal Article
Open access
ZMZifeng Mm Ma
Zifeng Mm Ma
ZXZhiyu Xiao
Zhiyu Xiao
PYPengfei Mm Yin
Pengfei Mm Yin
KWKai Wen
Kai Wen
WWWeidong Wang
Weidong Wang
KMKai Mao
Kai Mao
Objective: The objective of this study is to evaluate and compare the survival benefit and safety of surgery following conversion therapy versus surgery alone in patients diagnosed with surgically resectable hepatocellular carcinoma (HCC) at China Liver Cancer Staging (CNLC) IIb/IIIa stage. Methods: A total of 95 patients diagnosed with surgically resectable CNLC IIb/IIIa HCC were retrospectively enrolled in our study from November 2018 to December 2022. Among them, 30 patients underwent conversion therapy followed by hepatectomy, while the remaining 65 received surgery alone. The primary endpoint was recurrence-free survival (RFS). Propensity score matching was employed to minimize bias in the retrospective analysis. Results: Compared to the surgery alone group, the conversion therapy group demonstrated a significantly prolonged median RFS (17.1 vs. 7.0 months; P=0.014), a reduced incidence of microvascular invasion (MVI, 23.3 vs. 81.5%; P<0.001), and a comparable rate of achieving Textbook Outcome in Liver Surgery (TOLS, 83.3 vs. 76.9%; P=0.476). Multivariate analysis indicated that conversion therapy was independently associated with improved RFS after hepatectomy (HR=0.511, P=0.027). The same conclusions were obtained after propensity score matching. Conclusions: The findings of our study offer preliminary evidence that preoperative conversion therapy significantly prolongs RFS in patients with surgically resectable HCC at CNLC IIb/IIIa stage. Furthermore, combining conversion therapy and hepatectomy represents a relatively safe treatment strategy.

22 September 2026 in BMC Cancer
Verified
Journal Article
Open access
PDF file
QLQiaohong Lin
Qiaohong Lin
WWWeidong Wang
Weidong Wang
KWKai Wen
Kai Wen
MTMeng Tao
Meng Tao
JWJiahua Wen
Jiahua Wen
ZXZhiyu Xiao
Zhiyu Xiao
This study aimed to identify prognostically relevant genes from a platinum resistance-related pathway and to develop a concise signature for predicting ove